QUOTED. 20 February 2020. Steven Raman.
Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Here's what one researcher in the area, Steven Raman, had to say about the new options.
"There are two very unique things about this system. First, you can control with much more finesse where you're going to treat, preserving continence and sexual function. Second, you can do this for both diffuse and localized prostate cancer and benign diseases, including benign hyperplasia." – Steven Raman, professor of radiology and urology, University of California, Los Angeles
Click here for a free trial of Medtech Insight